m+Medelevator.RU
← Поиск публикаций
bioRxiv : the preprint server for biology · 2026

Ileitis abolishes tolerogenic functions of the enterohepatic bile acid pool.

СтатьяПрепринтНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Xiao Zhiping, Sudo Koichi, Delmas-Eliason Amber, Liu Jiabao, Munoz-Tello Paola A, Dionne Henry D, Nguyen Fiona, Hondros Alexander D, Yang Huijuan, Hamilton B JoNell, Balasubramanian Akshaya, Hegner Courtney L, Jacobsen Gilian, Tonzi Erin M, Kaul Ila K, Soucy Shannon, Siegel Corey A, O'Toole George A, Schultz Daniel, Weaver Casey T, Rodriguez-Palacios Alex, Cominelli Fabio, Krause Henry, Abreu Maria T, Dawson Paul A, Kojetin Douglas, Sundrud Mark S

Аннотация

Bile acids (BAs) regulate lipid uptake, epithelial integrity, and immune responses in the gut. Hepatocytes synthesize primary BAs, which microbiota metabolize into secondary metabolites. Together, these species form a composite pool that circulates enterohepatically between the liver and intestines. Here, we show that immunoregulatory outputs of the enterohepatic BA pools involve competition between multiple BA species for individual nuclear receptors and are dependent on intestinal health. In healthy mice, the primary BA, tauro β muricholic acid (tβMCA) antagonized RORγt-mediated Th17 function in the presence of two secondary BAs (tDCA, tLCA) which activated RORγt. Conversely, ileitis in Crohns disease patients and TnfδARE mice depleted primary BAs by reducing the number and function of BA transporting enterocytes. In mice, ileitis driven tβMCA depletion enhanced tDCA and tLCA mediated RORγt activation and supported Th17 cell function. Replenishing tβMCA in TnfδARE mice reestablished BA dependent Th17 cell regulation. Thus, intra pool competition underpins BA immunoregulatory functions and reveals new opportunities for precision Crohns disease therapy.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты